Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC. (6th November 2014) - Hilton, Traci; Sanborn, Rachel; Boulmay, Brian; Li, Rui; Spieler, Bradley; Happel, Kyle; Paustian, Christopher; Moudgil, Tarsem; Dubay, Christopher; Fisher, Brenda; Mederos, Eileen; Ochoa, Augusto; et al.